Skip to content

PEG ratio at other companies

Merck & Co. logo
Merck & Co.MRK
2.2×
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
9.6×+9.4×
Alkermes logo
AlkermesALKS
8.9×+8.6×
Organon logo
OrganonOGN
Royalty Pharma logo
Royalty PharmaRPRX
0.3×
United Therapeutics logo
United TherapeuticsUTHR
3.2×+2.4×

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Calculated from Innoviva, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s peg ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s PEG ratio?
Innoviva, Inc. (INVA) reported PEG ratio of 0× in Q4 2025.
What is the long-term trend for Innoviva, Inc.'s PEG ratio?
Over 2 years (2020 to 2025), Innoviva, Inc.'s PEG ratio has grown at a -69.1% compound annual growth rate (CAGR), from 0.1× to 0×.
What does PEG ratio mean?
The P/E ratio divided by the trailing-twelve-month net-income growth rate (in percentage points). Adjusts the earnings multiple for the pace of earnings growth.